NOTICE OF ALLOWANCE - ISSUED
issued
on 16 Jul 2024
Last Applicant/ Owned by
12278 Scripps Summit Drive
San Diego
CA
92131
Serial Number
97577537 filed on 02th Sep 2022
Registration Number
N/A
Correspondent Address
Jared M. Barrett
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
SENESCEA THERAPEUTICS
medical and medical clinical research and development for others in the field of cellular rejuvenation; medical and scientific research, namely, conducting preclinical research and clinical trials providing health and medical information; providing a website featuring health and medical information reagents for research purposes for drug discovery and development; Diagnostic reagents for clinica Read More
Classification Information
Class [044]
Medical, Beauty & Agricultural Services
providing health and medical information; providing a website featuring health and medical information
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [042]
Computer & Software Services & Scientific Services
medical and medical clinical research and development for others in the field of cellular rejuvenation; medical and scientific research, namely, conducting preclinical research and clinical trials
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Pharmaceutical and therapeutic agents for use in cellular regeneration and cellular rejuvenation; pharmaceutical and therapeutic agents for the treatment of age-related diseases, and the treatment of degenerative diseases; pharmaceutical and therapeutic agents for use in targeting or regulating senescent cells; pharmaceutical and therapeutic agents designed to directly target and regulate senescent cells for cellular regeneration, cellular rejuvenation to restore cell health, treatment of age-related diseases, treatment of degenerative diseases, anti-aging treatments, treatments to reverse human disease, and treatment of human disease; cells for regenerative medicine for the treatment of age-related diseases, treatment of degenerative diseases, anti-aging, to reverse human disease, and to directly target and regulate senescent cells; clinical medical reagents
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [001]
Chemical Products
reagents for research purposes for drug discovery and development; Diagnostic reagents for clinical or medical laboratory use
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 97577537
Mark Type
No Service Mark
Attorney Docket Number
No 321051.20002
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 16th Dec 2024 | SOU TEAS EXTENSION RECEIVED |
| 16th Jul 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 21st May 2024 | PUBLISHED FOR OPPOSITION |
| 21st May 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 01st May 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 15th Apr 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 28th Mar 2024 | EXAMINER'S AMENDMENT ENTERED |
| 28th Mar 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 28th Mar 2024 | EXAMINERS AMENDMENT E-MAILED |
| 28th Mar 2024 | EXAMINERS AMENDMENT -WRITTEN |